Autoinjectors Market Is Expected To Exhibit 18.1% CAGR By 2027 | Novartis AG, SHL Medical, Eli Lilly and Company

Rise in anaphylaxis cases and increases in R&D activities by key players in the market are anticipated to drive the market. Rapid growth has been observed in adoption of biosimilars over branded drugs, which provides low cost treatment options for patients.

The global autoinjectors industry was estimated at $1.50 billion in 2019, and is anticipated to hit $5.73 billion by 2027, registering a CAGR of 18.1% from 2020 to 2027.

Download Detailed COVID-19 Impact Sample Report at @ https://www.alliedmarketresearch.com/request-for-customization/1461?reqfor=covid

COVID-19 scenario-

• The outbreak of the pandemic has led to an increased demand for autoinjectors that can be used and monitored in the home environment.
• At the same time, although COVID-19 has brought effects on many aspects such as travel bans and quarantines, the restrictive measures have not been imposed on the healthcare industry, thereby leaving the global autoinjectors market unaffected.

Drivers, restraints, and opportunities-

Rise in prevalence of anaphylaxis, increase in preference among patients to choose self-administration of injections, and technological advancements in autoinjectors fuel the growth of the global autoinjectors market. On the other hand, availability of alternative treatment options such as general injections and oral tablets impedes the growth to some extent. However, patent expiry of biologics to fuel biosimilar demands is expected to create lucrative opportunities for the key players in the industry.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/1461

The disposable autoinjectors segment to dominate by 2027-

Based on type, the disposable autoinjectors segment accounted for more than two-thirds of the global autoinjectors market share in 2019 and is expected to rule the roost by the end of 2027. The same segment is also anticipated to register the fastest CAGR of 18.4% throughout the forecast period. This is because the key market players are highly focused on the development of autoinjector devices.

The home care settings segment to maintain the dominant share-

Based on end user, the home care settings segment contributed to more than three-fifths of the global autoinjectors market revenue in 2019 and is anticipated to lead the trail till 2027. Simultaneously, the same segment would also manifest the fastest CAGR of 18.3% during the study period. This is due to increased patient preference for autoinjectors and rise in prevalence of anaphylaxis.

North America garnered the major share in 2019-

Based on geography, North America generated the highest share in 2019, garnering more than two-fifths of the global autoinjectors market. This is attributed to higher awareness among people, increased adoption of autoinjectors, higher number of the target population, supportive reimbursement policies, and availability of advanced devices in the region. Asia-Pacific, on the other hand, would grow at the fastest CAGR of 18.6% from 2020 to 2027.

To know more about the report, visit the website at @ https://www.alliedmarketresearch.com/autoinjector-market

The major key players profile Are:

Amgen, Antares Pharma, Becton Dickinson and Company, Eli Lilly and Company, Johnson and Johnson, Mylan N.V., Novartis AG, SHL Medical, Teva Pharmaceutical Industries Ltd and Ypsomed AG.

Other Key players Are:

Biogen Idec, Owen Mumford, Consort Medical, Abbvie, and Gerresheimer.

Similar Reports:

Cell-based Assay Market : https://www.pharmiweb.com/press-release/2021-02-11/cell-based-assay-market-new-business-opportunities-is-expected-to-value-1061-billion-by-2023

Regenerative Medicine Market : https://www.pharmiweb.com/press-release/2021-02-11/regenerative-medicine-market-size-to-reach-usd-3932-billion-globally-by-2023

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.